In the business of Molecular diagnostics, ThirdLaw Tedhnologies LLC personnel are developing molecules called spiroligomers designed to replace monoclonal antibodies (mAbs) in point-of-care diagnostic tests. Far more robust than mAbs, Spiroligomers can remain active for decades. Made with synthetic chemistry, Spiroligomers have lower capital costs for manufacture, are much smaller than mAbs and can bind epitopes that mAbs cannot access. Anchored in just a few weeks' work, Active spiroligomers can be discovered and manufactured for diagnostic tests .
